Philip Croxford

Philip M.
Croxford is currently the President & Chief Executive Officer at Gamma Medica, Inc., a Director at Etac AB, and a Member of the Royal Pharmaceutical Society of Great Britain.
Previously, he held positions such as President, Chief Executive Officer & Director at Draeger Medical, Inc., President & Chief Executive Officer at Arjo, Inc., Director at Johnson & Johnson, Director at Smith & Nephew plc, Independent Director at Vital Therapies, Inc., Director-Worldwide Marketing at Johnson & Johnson Medical, Inc., President-Regenerative Medicine at LifeCell Corp., Vice President-Critical Care & Cardiac Assist at Arrow International LLC, Vice President-Worldwide Wound Management at Ethicon, Inc., Vice President-Sales & Marketing at Advanced Wound Care Pty Ltd., and Principal at Acelity Holdings, Inc. He obtained an undergraduate degree from The University of Manchester and an MBA from Edinburgh Business School.